The Potential Impact of Clindamycin on Neurosurgery Patients.
Status:
Completed
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
A prospective, open-label, single center, controlled trial. 44 patients that underwent
neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy to assess its
effect on neurological complication in relation to Neuron-specific enolase (NSE) and
Neurotensin biomarkers levels.